MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0018382
Innosyn Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.04 Cr
▲ 26% YoY
Net profit · FY 2025
₹2.25 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹34 Lakh
EBITDA margin 11.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
9
Provident fund records
Directors on board
2
As per MCA filings
About Innosyn Life Sciences Private Limited
Data last updated:
Innosyn Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 27 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2017PTC117973. Its GSTIN is 36AAECI5451L1ZB (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ramesh Babu Anagani (Managing Director) and Shilpa Gudibandla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.133/1/A Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.04 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹2.25 Lakh (net margin 0.7%) and EBITDA of ₹34 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 29% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Innosyn Life Sciences. Court records list 2 cases involving the company, including 2 filed against it.
Innosyn Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0018382). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innosynlifesciences.com.
Company details
CIN U74999TG2017PTC117973
Registration Number 117973
Incorporation Date 27 June 2017
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0018382
Recognitions & Rankings of Innosyn Life Sciences
Contact details
Innosyn Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is innosynlifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.133/1/A Phase – II Ida Cherlapally, Hyderabad, Telangana, India – 500051
- IndustryPharma, API Manufacturers
To see the full contact details of Innosyn Life Sciences Private Limited, buy the company report.
Comprehensive company report
Innosyn Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Innosyn Life Sciences operates one associated brand: Innosyn Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Synthesis of pharmaceutical intermediates and provision of custom services in life sciences. | innosynlifesciences.com |
Business activity
The main business activity of Innosyn Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innosyn Life Sciences Private Limited, buy the company report.
Financials of Innosyn Life Sciences Private Limited
FY 2024 filings availableInnosyn Life Sciences Private Limited reported revenue of ₹3.04 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹3.04 Cr ▲ 26%
Net profit · FY 2025
₹2.25 Lakh margin 0.7%
EBITDA · FY 2025
₹34 Lakh margin 11.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 7%
5 years · compounded
▲ 29%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▼ 15%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 26% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹34 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.25 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innosyn Life Sciences Private Limited, buy the company report.
Board of directors of Innosyn Life Sciences Private Limited
Innosyn Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Babu Anagani | Managing Director | 27 Jun 2017 | 9 Years 3 Months | Current |
| Shilpa Gudibandla | Director | 27 Jun 2017 | 9 Years 3 Months | Current |
Peer comparison
Innosyn Life Sciences Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mekanar Pharma Private Limited | ₹3.2 Cr (FY 2025) | 50.0% | Hyderabad, Telangana, India | |||
| Cil Laboratories Private Limited | ₹3.14 Cr (FY 2023) | 26590.0% | Kolkata, West Bengal, India | |||
| Vvic Pharma Private Limited | ₹3.14 Cr (FY 2025) | 303.0% | Ankleshwar, Gujarat, India | |||
| Sthree Chemicals Private Limited | ₹3.11 Cr (FY 2024) | -53.0% | Walajapet, Tamil Nadu, India | |||
| Supreme Drugs Private Limited | ₹3.08 Cr (FY 2024) | 1350.0% | Banaskatha, Gujarat, India | |||
| Innosyn Life Sciences Private Limitedthis company | ₹3.04 Cr (FY 2025) | ₹2.25 Lakh | 0.7% | 26.0% | 9 | Hyderabad, Telangana, India |
| Nic Bioscience Private Limited | ₹3.03 Cr (FY 2025) | 17.0% | Ankleshwar, Gujarat, India | |||
| Vandana Life Sciences Private Limited | ₹2.82 Cr (FY 2025) | -54.0% | Hyderabad, Telangana, India | |||
| Troikaa Pharmachem Private Limited | ₹2.57 Cr (FY 2025) | 5490.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Innosyn Life Sciences Private Limited, buy the company report.
Auditor
Innosyn Life Sciences Private Limited is audited by SHEKARSANDA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHEKARSANDA | FY 2023 | 230977 |
Shareholding
The shareholding of Innosyn Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Innosyn Life Sciences Private Limited, buy the company report.
Legal cases
Innosyn Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by M/S Chromachemie Laboratory Pvt Ltd | Disposed |
| District court, BENGALURU, Karnataka | Criminal complaint | Filed against the company by M/S Chromachemie Laboratory Pvt Ltd | Disposed |
To see the full case history of Innosyn Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Innosyn Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (2 of 2)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Azole Chem Private Limited | |||
| an individual supplier |
To see the full MSME payment records of Innosyn Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Innosyn Life Sciences Private Limited has a workforce of 9 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
9
Active EPFO establishments
1
Employee growth
28.57%
GST
Innosyn Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAECI5451L1ZB | Telangana | Active | 21 Aug 2017 |
To see the full GST registrations and return filing status of Innosyn Life Sciences Private Limited, buy the company report.
Recent activity
Innosyn Life Sciences Private Limited has 5 board changes on record since 2017: 2 appointments and 3 cessations. The latest: Cheguru Kumari Krishna ceased to be Director on 18 Mar 2019.
AGM
Innosyn Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Innosyn Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Cheguru Kumari Krishna ceased to be Director.
Ceased
Swathi Vuyyuru ceased to be Director.
Ceased
Nagaraju Marepu ceased to be Director.
Appointed
Ramesh Babu Anagani was appointed as Managing Director.
Appointed
Shilpa Gudibandla was appointed as Director.
Incorporation
27 Jun 2017
Innosyn Life Sciences Private Limited was registered on 27 Jun 2017 with Roc Hyderabad & aged 9 years 3 months as per MCA records.
Frequently asked questions
Innosyn Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 27 June 2017 (9+ years old) and is registered under CIN U74999TG2017PTC117973.
Innosyn Life Sciences has 2 current directors:
- Ramesh Babu Anagani - Managing Director
- Shilpa Gudibandla - Director
The latest financial statements of Innosyn Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Innosyn Life Sciences is 36AAECI5451L1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Innosyn Life Sciences is U74999TG2017PTC117973. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innosyn Life Sciences has 2 court cases on record: 2 filed against it.
Innosyn Life Sciences was incorporated on 27 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Innosyn Life Sciences by revenue are Mekanar Pharma Private Limited, Cil Laboratories Private Limited, Vvic Pharma Private Limited, Sthree Chemicals Private Limited, Supreme Drugs Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Cheguru Kumari Krishna ceased to be Director on 18 Mar 2019. Swathi Vuyyuru ceased to be Director on 07 Mar 2019. Nagaraju Marepu ceased to be Director on 24 Jul 2017. Innosyn Life Sciences has 5 board changes on record in total.
Yes, Innosyn Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0018382).
Innosyn Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 2 micro and small suppliers. The latest return was filed on 30 May 2019.
Innosyn Life Sciences can be reached through the website innosynlifesciences.com. Its registered office is in Hyderabad, Telangana, India.